OCUL: Ocular Therapeutix Inc. filed SEC Form 8-K: Other Events
Stocks in this Quantisnow insightHealth Care
Historical context for OCUL
Across the 6 sessions after earlier OCUL headlines, the stock closed higher 3 times and lower 3 times, with a median move of 1.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | OCUL | SPY |
|---|---|---|---|
| Dec 5, 2025 | Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | +1.2% | +0.2% |
| Nov 24, 2025 | Ocular Therapeutix™ Announces First Patient Randomized in HELIOS-3 Phase 3 Registrational Program for AXPAXLI™ in NPDR | -1.1% | +1.5% |
| Nov 12, 2025 | Ocular Therapeutix™ to Participate in November and December Investor Conferences | +2.4% | +0.1% |
| Nov 7, 2025 | Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | +2.1% | +0.1% |
| Nov 4, 2025 | Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlightsand 1 other headline that session | -4.5% | -1.2% |
| Oct 28, 2025 | Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025 | -0.2% | +0.3% |
Quantisnow market dataNASDAQ
OCUL
Ocular Therapeutix Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2014
Get push alerts for OCUL
Full OCUL profile on Quantisnow Follow OCUL and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time